ZBIO · Zenas BioPharma, Inc. · Executive Compensation
$27.02
-0.24 (-0.88%)
At close · Oct 12
Return incl. dividend (before tax)
Market Cap
$1.78B
Shares
65.18M
Volume · Oct 12
23.42K
Avg daily vol (3M)
728.69K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Leon O. Moulder | Founder, Chief Executive Officer and Chairman | $4,661,000 |
| Lisa von Moltke | Head of Research and Development and Chief Medical Officer | $3,499,447 |
| Joseph L. Farmer | President and Chief Operating Officer | $2,526,525 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Leon O. Moulder | Founder, Chief Executive Officer and Chairman | $19,998,016 |
| Joseph L. Farmer | President and Chief Operating Officer | $6,004,454 |
| Jennifer Fox | Chief Business Officer and Chief Financial Officer | $4,835,306 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Leon O. Moulder | Founder, Chief Executive Officer and Chairman | $2,601,510 |
| Jennifer Fox | Chief Business Officer and Chief Financial Officer | $2,566,608 |
| Joseph L. Farmer | President and Chief Operating Officer | $1,293,983 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jennifer Fox | Strategic Advisor to the Board Chair | Appointed | 2026-08-13 |
| Christy J. Oliger | Class II director | Appointed | 2026-08-13 |
| Tomas Kiselak | Board of Directors | Resigned | 2026-05-13 |
| Hongbo Lu, Ph.D. | Class I director | Appointed | 2025-06-12 |
| Leon O. Moulder, Jr. | Class I director | Appointed | 2025-06-12 |
| Ting (Tim) Xiao | Board of Directors | Resigned | 2025-06-12 |